Literature DB >> 3143407

Inhibition of serine palmitoyltransferase in vitro and long-chain base biosynthesis in intact Chinese hamster ovary cells by beta-chloroalanine.

K A Medlock1, A H Merrill.   

Abstract

The effects of beta-chloroalanine (beta-Cl-alanine) on serine palmitoyltransferase activity and the de novo biosynthesis of sphinganine and sphingenine were investigated in vitro with rat liver microsomes and in vivo with intact Chinese hamster ovary (CHO) cells. The inhibition in vitro was rapid (5 mM beta-Cl-alanine caused complete inactivation in 10 min), irreversible, and concentration and time dependent and apparently involved the active site because inactivation only occurred with beta-Cl-L-alanine (not beta-Cl-D-alanine) and was blocked by L-serine. These are characteristics of mechanism-based ("suicide") inhibition. Serine palmitoyltransferase (SPT) was also inhibited when intact CHO cells were incubated with beta-Cl-alanine (complete inhibition occurred in 15 min with 5 mM), and this treatment inhibited [14C]serine incorporation into long-chain bases by intact cells. The concentration dependence of the loss of SPT activity and of long-chain base synthesis was identical. The effects of beta-Cl-L-alanine appeared to occur with little perturbation of other cell functions: the cells exhibited no loss in cell viability, [14C]serine uptake was not blocked, total lipid biosynthesis from [14C]acetic acid was not decreased (nor was the appearance of radiolabel in cholesterol and phosphatidylcholine), and [3H]thymidine incorporation into DNA was not affected. There appeared to be little effect on protein synthesis based on the incorporation of [3H]leucine, which was only decreased by 14%. Although beta-Cl-L-alanine is known to inhibit other pyridoxal 5'-phosphate dependent enzymes, alanine and aspartate transaminases were not inhibited under these conditions. These results establish the close association between the activity of serine palmitoyltransferase and the cellular rate of long-chain base formation and indicate that beta-Cl-alanine and other mechanism-based inhibitors might be useful to study alterations in cellular long-chain base synthesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143407     DOI: 10.1021/bi00418a061

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

Review 2.  Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.

Authors:  Jeremy Shaw; Pedro Costa-Pinheiro; Logan Patterson; Kelly Drews; Sarah Spiegel; Mark Kester
Journal:  Adv Cancer Res       Date:  2018-06-19       Impact factor: 6.242

3.  Lipid synthesis inhibitors: effect on epidermal lipid conformational changes and percutaneous permeation of levodopa.

Authors:  Kumar Babita; Vikas Rana; Ashok K Tiwary
Journal:  AAPS PharmSciTech       Date:  2005-10-24       Impact factor: 3.246

Review 4.  Approaches for probing and evaluating mammalian sphingolipid metabolism.

Authors:  Justin M Snider; Chiara Luberto; Yusuf A Hannun
Journal:  Anal Biochem       Date:  2019-03-24       Impact factor: 3.365

5.  Drug Development in the Field of Sphinogolipid Metabolism.

Authors:  Zhibei Qu; Lu Zhou
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Ceramide signaling in cancer and stem cells.

Authors:  Erhard Bieberich
Journal:  Future Lipidol       Date:  2008-06

7.  Diacylglycerol generated during sphingomyelin synthesis is involved in protein kinase C activation and cell proliferation in Madin-Darby canine kidney cells.

Authors:  Jorge Cerbón; Rosa del Carmen López-Sánchez
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

8.  Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.

Authors:  W M Holleran; M Q Man; W N Gao; G K Menon; P M Elias; K R Feingold
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

Review 9.  Novel chemotherapeutic drugs in sphingolipid cancer research.

Authors:  Daniel Canals; Yusuf A Hannun
Journal:  Handb Exp Pharmacol       Date:  2013

10.  Variations of ganglioside biosynthetic pathways in the phenotype conversion from myofibroblasts to lipocytes in murine hepatic stellate cell line.

Authors:  Aline B de Aguirres; Paola A Mello; Claudia M B Andrade; Ana Carolina Breier; Rogério Margis; Regina M Guaragna; Radovan Borojevic; Fátima C R Guma; Vera M T Trindade
Journal:  Mol Cell Biochem       Date:  2007-04-18       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.